Cytek Biosciences (CTKB) Raw Materials (2020 - 2026)

Cytek Biosciences has reported Raw Materials for 7 years, with the latest figure at $23.6 million in Q1 2026.

• For the quarter ending Q1 2026, Raw Materials changed 0.4% year-over-year to $23.6 million; the trailing twelve-month figure through Mar 2026 stood at $23.6 million (changed 0.4% YoY), and the FY2025 full-year result was $20.4 million, down 9.43% from the prior year.
• Raw Materials for Q1 2026 stood at $23.6 million, up from $20.4 million in the prior quarter.
• The five-year high for Raw Materials was $42.2 million in Q1 2023, with the low at $20.4 million in Q4 2025.
• Historically, Raw Materials has averaged $28.7 million across 5 years, with a median of $26.8 million in 2024.
• Annual changes were most pronounced in 2023 — Raw Materials soared 99.18% — and 2024, when it tumbled 36.81%.
• Cytek Biosciences' Raw Materials stood at $26.9 million in 2022, then jumped by 32.66% to $35.7 million in 2023, then plunged by 36.81% to $22.6 million in 2024, then dropped by 9.43% to $20.4 million in 2025, then grew by 15.65% to $23.6 million in 2026.
• The last three Raw Materials figures came in at $23.6 million (Q1 2026), $20.4 million (Q4 2025), and $24.7 million (Q3 2025), per Business Quant data.